Amanda Oster, Program Director of Healthy Work Environment at IU Health, and Eric Williams, Staff Chaplain at IU Health, presented a Fairbanks Ethics Grand Rounds on Healthcare Provider Wellbeing. The talk highlighted the importance of provider well-being and discussed evidence-based interventions to promote wellness among healthcare providers who are often taxed by an environment that… Read more »
Commentary
Is Opaque Reasoning Justifiable in Healthcare?
Is explainability necessary for using AI in medicine? I argue that without understanding what happens in the opaque reasoning process, interpretable AI is impractical in many facets of healthcare without human redundancy.
Developing AI and Limiting Risk: An Impossible Balancing Act?
How should we operationalize AI risk? It depends on who you ask. Dario Amodei and the team at Anthropic propose AI safety level standards in an effort to standardize the risks of various LLM models.[1] He is among the most concerned about the risks of AI, or as much as the CEO of an AI company can… Read more »
Insulin Price Controls, Who Falls Through the Gaps?
In the United States, 6 million people take insulin to control their type 2 diabetes. In recent years, the high price of insulin has been widely covered in the media. Disturbing stories of insulin rationing and patient deaths have been widely reported. A Yale study from 2018 found that 1 in 4 patients with diabetes were cutting back on insulin… Read more »
Who Deserves Ozempic? The Ethical Challenges of Weight-Loss Use.
There isn’t enough Ozempic for everyone who wants it. People with health conditions like type 2 diabetes and severe obesity should get it before people who hope to lose a few pounds. As the new ‘miracle drug’ for weight loss, Ozempic is one of the most popular new drugs in America. This has come mostly… Read more »
Social media use by patients with hypermobile EDS
*For open access link to the full article click here Every 6.4 seconds a new social media account is created. Since the rise of social media in the early 2000s, access to connection online has multiplied tenfold. On the average day, we spend about 2 and a half hours scrolling through social media. And this number… Read more »
On the Increase in Use of GLP-1s
Ozempic is suddenly a household brand name, akin to Aleve, Advil, or Nyquil. Many people are calling Ozempic, and other drugs like it, “miracle drugs.” Ozempic and Mounjaro are part of a class of drugs called GLP-1 receptor agonists (GLP-1s for short). Ozempic was approved by the F.D.A. in 2017, while Mounjaro, Ozempic’s primary competitor, was approved in 2022. Both were approved in the U.S. by the F.D.A. to help lower blood sugar. Soon after the drugs… Read more »
NaloxBoxes
An odd looking box has shown up at the Campus Center at Indiana University – Purdue University, Indianapolis (IUPUI) on the first floor in the Vermont Street parking garage. It’s a 24/7 “Opioid Rescue Kit” filled with naloxone nasal spray, and seeing it should make us all ecstatic. There’s also a vending machine filled with free naloxone nasal… Read more »